Pathology and Lab Medicine

1-16 of 47

• 

  MinuteCE®

  Treatment Intensification in HSPC: From Risk Stratification to Precision Medicine

  Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD

  1.00 credit 6 episodes

  • 

    

    Scott T. Tagawa, MD, MS

  • 

    

    Mary-Ellen Taplin, MD

  1.00 credit 6 episodes

• 

  RestartResume

  Molecular Profiling in mHSPC: Informing Treatment Selection

  RestartResume

  Molecular Profiling in mHSPC: Informing Treatment Selection

  MinuteCE®

  Molecular Profiling in mHSPC: Informing Treatment Selection

  Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD

  1.00 program credit

  • 

    

    Scott T. Tagawa, MD, MS

  • 

    

    Mary-Ellen Taplin, MD

  1.00 program credit

• 

  RestartResume

  Targeting PTEN: Why It Matters

  RestartResume

  Targeting PTEN: Why It Matters

  MinuteCE®

  Targeting PTEN: Why It Matters

  Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD

  1.00 program credit

  • 

    

    Scott T. Tagawa, MD, MS

  • 

    

    Mary-Ellen Taplin, MD

  1.00 program credit

• 

  RestartResume

  Winning the Battle Against Side Effects: Adverse Event Management in HSPC

  RestartResume

  Winning the Battle Against Side Effects: Adverse Event Management in HSPC

  MinuteCE®

  Winning the Battle Against Side Effects: Adverse Event Management in HSPC

  Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD

  1.00 program credit

  • 

    

    Scott T. Tagawa, MD, MS

  • 

    

    Mary-Ellen Taplin, MD

  1.00 program credit

• 

  RestartResume

  De Novo mHSPC: Recognizing the Patients Who Need More

  RestartResume

  De Novo mHSPC: Recognizing the Patients Who Need More

  MinuteCE®

  De Novo mHSPC: Recognizing the Patients Who Need More

  Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD

  1.00 program credit

  • 

    

    Scott T. Tagawa, MD, MS

  • 

    

    Mary-Ellen Taplin, MD

  1.00 program credit

• 

  RestartResume

  Case: Implementing ADT Intensification in mHSPC

  RestartResume

  Case: Implementing ADT Intensification in mHSPC

  MinuteCE®

  Case: Implementing ADT Intensification in mHSPC

  Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD

  1.00 program credit

  • 

    

    Scott T. Tagawa, MD, MS

  • 

    

    Mary-Ellen Taplin, MD

  1.00 program credit

• 

  RestartResume

  ADT Intensification: The Evidence You Can’t Afford to Miss

  RestartResume

  ADT Intensification: The Evidence You Can’t Afford to Miss

  MinuteCE®

  ADT Intensification: The Evidence You Can’t Afford to Miss

  Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD

  1.00 program credit

  • 

    

    Scott T. Tagawa, MD, MS

  • 

    

    Mary-Ellen Taplin, MD

  1.00 program credit

• 

  RestartResume

  Decoding epNECs: Diagnostic Challenges and Emerging Strategies

  RestartResume

  Decoding epNECs: Diagnostic Challenges and Emerging Strategies

  Project Oncology®

  Decoding epNECs: Diagnostic Challenges and Emerging Strategies

  Brian P. McDonough, MD, FAAFP; Andrew E. Hendifar, MD

  • 

    

    Brian P. McDonough, MD, FAAFP

  • 

    

    Andrew E. Hendifar, MD

• 

  RestartResume

  Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3

  RestartResume

  Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3

  Project Oncology®

  Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3

  Charles Turck, PharmD, BCPS, BCCCP; Rohit Thummalapalli, MD

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Rohit Thummalapalli, MD

• 

  RestartResume

  Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies

  RestartResume

  Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies

  Project Oncology®

  Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies

  Alexandria May, PharmD, BCPS; Chandrikha Chandrasekharan, MBBS

  • 

    

    Alexandria May, PharmD, BCPS

  • 

    

    Chandrikha Chandrasekharan, MBBS

• 

  RestartResume

  Navigating Classification of High-Grade Neuroendocrine Neoplasms

  RestartResume

  Navigating Classification of High-Grade Neuroendocrine Neoplasms

  Project Oncology®

  Navigating Classification of High-Grade Neuroendocrine Neoplasms

  Charles Turck, PharmD, BCPS, BCCCP; Rohit Thummalapalli, MD

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Rohit Thummalapalli, MD

• 

  RestartResume

  Turning Cold Tumors Hot with mRNA COVID-19 Vaccines

  RestartResume

  Turning Cold Tumors Hot with mRNA COVID-19 Vaccines

  COVID-19: On The Frontlines

  Turning Cold Tumors Hot with mRNA COVID-19 Vaccines

  Hallie Blevins, PhD; Marlene Mimi Maeusli, PhD.

  • 

    

    Hallie Blevins, PhD

  • 

    

    Marlene Mimi Maeusli, PhD.

• 

  RestartResume

  Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care

  RestartResume

  Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care

  CME/CE

  Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care

  Joseph Kim, MD, MPH, MBA, FACHE; Samir Dalia, MD

  0.25 credits

  • 

    

    Joseph Kim, MD, MPH, MBA, FACHE

  • 

    

    Samir Dalia, MD

  • 

    

    Christopher Jurief

  0.25 credits

• 

  RestartResume

  Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery

  RestartResume

  Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery

  Clinician's Roundtable

  Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery

  Ashley Baker, MSN, PMHNP; Heather Allen, PhD

  • 

    

    Ashley Baker, MSN, PMHNP

  • 

    

    Heather Allen, PhD

  • 

    

    Ran Li, PhD

• 

  RestartResume

  Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer

  RestartResume

  Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer

  Project Oncology®

  Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer

  Matt Birnholz, MD

  • 

    

    Matt Birnholz, MD

• 

  RestartResume

  Perioperative Immunotherapy Strategies in Resectable NSCLC Care

  RestartResume

  Perioperative Immunotherapy Strategies in Resectable NSCLC Care

  Project Oncology®

  Perioperative Immunotherapy Strategies in Resectable NSCLC Care

  Charles Turck, PharmD, BCPS, BCCCP; Martin Dietrich, MD, PhD

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

  • 

    

    Martin Dietrich, MD, PhD

• Prev
• 1
• 2
• 3
• Next